Mobia Medical, Inc. (MOBI)

Market Cap	352.22M
Revenue (ttm)	45.28M +104.8%
Net Income	-64.14M
EPS	-9.35
Shares Out	33.29M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	210,604
Open	9.53
Previous Close	9.64
Day's Range	9.53 - 10.63
52-Week Range	8.03 - 15.29
Beta	n/a
Analysts	Strong Buy
Price Target	17.75 (+67.77%)
Earnings Date	Nov 5, 2026

About MOBI

Mobia Medical, Inc. develops and commercializes neurostimulation medical devices, including implantable systems for stroke rehabilitation and other neurological conditions. The company provides neurostimulation systems and devices that combine vagus nerve stimulation with therapy to address chronic neurological conditions. Its main product, the Vivistim System, is an FDA-approved implantable device designed to aid in the rehabilitation of upper limb motor function in post-stroke patients. The paired VNS platform is used to help patients relearn...

• Industry: Medical Devices
• Sector: Healthcare
• IPO Date: May 8, 2026
• Employees: 167
• Stock Exchange: Nasdaq
• Ticker Symbol: MOBI
• Website: https://www.mobia.com

Analyst Summary

According to 4 analysts, the average rating for MOBI stock is "Strong Buy." The 12-month stock price target is $17.75, which is an increase of 67.77% from the latest price.

Price Target

$17.75

(67.77% upside)

Analyst Consensus: Strong Buy

Data Sources: S&P Global Market Intelligence, CBOE, and more

Fundamental and historical data is provided by S&P Global Market Intelligence. Real-time stock price data is provided by CBOE and 15-minute delayed consolidated tape pricing data is provided by Nasdaq UTP.

Last checked:

Oct 23, 2026

Data Sources Report a data error